1. Intravesicular mitomycin restricted to bladder cancer only

   News item 26 October 2019 Pages: 1 - 1

2. New safety information for alemtuzumab; revised indication

   News item 26 October 2019 Pages: 2 - 2

3. Risk of blood clots, death with high-dose tofacitinib

   News item 26 October 2019 Pages: 3 - 3

4. SFDA warns of neuropsychiatric reactions with montelukast

   News item 26 October 2019 Pages: 4 - 4

5. Angiotensin receptor antagonists increase risk of suicide

   Clinical study 26 October 2019 Pages: 5 - 5

6. Antidepressants increase risk of gestational diabetes

   Clinical study 26 October 2019 Pages: 6 - 6

7. Corticosteroids increase risk of cataracts, diabetes, fractures

   Clinical study 26 October 2019 Pages: 7 - 7

8. Global report on AEs in patients with drug-resistant TB

   Clinical study 26 October 2019 Pages: 8 - 8

9. Medication error safety concerns associated with approved drugs

   Clinical study 26 October 2019 Pages: 9 - 9

10. New safety signals for asthma drugs in children

    Clinical study 26 October 2019 Pages: 10 - 10

11. Statin-related osteoporosis is dose-dependent

    Clinical study 26 October 2019 Pages: 11 - 11

12. Statins increase risk of skin infections and diabetes

    Clinical study 26 October 2019 Pages: 12 - 12

13. Abacavir

    Case report 26 October 2019 Pages: 13 - 13

14. Aceclofenac

    Case report 26 October 2019 Pages: 14 - 14

15. Aceclofenac/diclofenac

    Case report 26 October 2019 Pages: 15 - 15

16. Adalimumab

    Case report 26 October 2019 Pages: 16 - 16

17. Adalimumab/azathioprine

    Case report 26 October 2019 Pages: 17 - 17

18. Adalimumab/azathioprine

    Case report 26 October 2019 Pages: 18 - 18

19. Adalimumab/etanercept/infliximab

    Case report 26 October 2019 Pages: 19 - 19

20. Adalimumab/infliximab/vedolizumab

    Case report 26 October 2019 Pages: 20 - 20

21. Aflibercept/bevacizumab/ranibizumab

    Case report 26 October 2019 Pages: 21 - 21

22. Alemtuzumab

    Case report 26 October 2019 Pages: 22 - 22

23. Alemtuzumab

    Case report 26 October 2019 Pages: 23 - 23

24. Alemtuzumab

    Case report 26 October 2019 Pages: 24 - 24

25. Alemtuzumab

    Case report 26 October 2019 Pages: 25 - 25

26. Alemtuzumab

    Case report 26 October 2019 Pages: 26 - 26

27. Alemtuzumab

    Case report 26 October 2019 Pages: 27 - 27

28. Alemtuzumab

    Case report 26 October 2019 Pages: 28 - 28

29. Alemtuzumab

    Case report 26 October 2019 Pages: 29 - 29

30. Alemtuzumab

    Case report 26 October 2019 Pages: 30 - 30

31. Alemtuzumab

    Case report 26 October 2019 Pages: 31 - 31

32. Alemtuzumab

    Case report 26 October 2019 Pages: 32 - 32

33. Alemtuzumab

    Case report 26 October 2019 Pages: 33 - 33

34. Alemtuzumab

    Case report 26 October 2019 Pages: 34 - 34

35. Alendronic acid/zoledronic acid

    Case report 26 October 2019 Pages: 35 - 35

36. Allopurinol

    Case report 26 October 2019 Pages: 36 - 36

37. Allopurinol

    Case report 26 October 2019 Pages: 37 - 37

38. Allopurinol

    Case report 26 October 2019 Pages: 38 - 38

39. Allopurinol/antibacterials

    Case report 26 October 2019 Pages: 39 - 39

40. Allopurinol/lamotrigine/vancomycin

    Case report 26 October 2019 Pages: 40 - 40

41. Alteplase/heparin/unspecified vasoactive drugs

    Case report 26 October 2019 Pages: 41 - 41

42. Amikacin-sulfate

    Case report 26 October 2019 Pages: 42 - 42

43. Amiodarone/digoxin/propafenone

    Case report 26 October 2019 Pages: 43 - 43

44. Amiodarone/thiamazole

    Case report 26 October 2019 Pages: 44 - 44

45. Amisulpride/olanzapine/quetiapine

    Case report 26 October 2019 Pages: 45 - 45

46. Amoxicillin

    Case report 26 October 2019 Pages: 46 - 46

47. Amoxicillin

    Case report 26 October 2019 Pages: 47 - 47

48. Amoxicillin

    Case report 26 October 2019 Pages: 48 - 48

49. Amoxicillin

    Case report 26 October 2019 Pages: 49 - 49

50. Amoxicillin

    Case report 26 October 2019 Pages: 50 - 50